Zobrazeno 1 - 10
of 979
pro vyhledávání: '"59"'
Autor:
Octavio Corral Pazos de Provens, Jesús María Aranaz Andrés, Jose Yuste Lobo, Luis Manzano Espinosa, Abelardo Claudio Fernández Chávez, Luis García Comas
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases
Repisalud
Instituto de Salud Carlos III (ISCIII)
Re-Unir. Archivo Institucional de la Universidad Internacional de La Rioja
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
Re-Unir. Archivo Institucional de la Universidad Internacional de La Rioja
instname
The major goals of the study were to describe the invasive pneumococcal disease (IPD) cases due to erythromycin-resistant serotypes and to evaluate the association between these cases and recent macrolide use in individuals aged over 59 years. We sel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15a641b5d984bac09ea0e1256def7072
https://hdl.handle.net/20.500.12105/14294
https://hdl.handle.net/20.500.12105/14294
Autor:
Thomas Le Gallou, Martin Killian, Margaux Garzaro, Maxime Samson, Ludovic Trefond, Sébastien Abad, Bertrand Godeau, Claire de Moreuil, Olivier Aumaître, Claire Blanchard-Delaunay, Yvan Jamilloux, Eric Hachulla, Arnaud Hot, Nicolas Girszyn, Estibaliz Lazaro, Thomas Papo, Thierry Martin, Bruno Crestani, Cécile-Audrey Durel, Pascal Cohen, Stéphane Durupt, Benjamin Terrier, Vincent Cottin, Eric Liozon, Alexandre Belot, Patrick Jego, Pascal Pillet, Loïc Guillevin, Antoinette Perlat, Fleur Cohen-Aubard, Grégory Pugnet
Publikováno v:
Rheumatology (Oxford, England). 58(9)
Objective Orbital mass is a rare and sight-threatening manifestation of ANCA-associated vasculitides, which remains a therapeutic challenge. We aimed to describe the presentation, therapeutic management and outcome of ANCA-associated vasculitides-rel
Autor:
Kazunobu Tachibana, Katsuhiro Suzuki, Masanori Akira, Yu Kurahara, Seiji Hayashi, Kazunari Tsuyuguchi
Publikováno v:
Respiratory Investigation. 52(3):160-166
Background Pulmonary nocardiosis is a rare but severe infection caused by Nocardia species. This study aimed at describing the clinical characteristics and prognosis of pulmonary nocardiosis. Methods An observational, retrospective study was undertak
Autor:
Ghandi Damaj, Odile Beyne-Rauzy, Borhane Slama, Stéphane Cheze, E. Berger, Francois Dreyfus, A. Kolb, L. Ades, F Bauduer, S Ayari, Raphael Itzykson, Norbert Vey, Felipe Suarez, Laurence Legros, Xavier Thomas, Martine Gardembas, Fatiha Chermat, M.C. Chaury, D. Vassilief, Pierre Fenaux, Agnès Guerci, Aspasia Stamatoullas
Publikováno v:
Leukemia. 23:673-678
Erythropoiesis-stimulating agents (ESAs) remain the first-line treatment of anemia in lower risk myelodysplastic syndromes (MDS) without 5q deletion. A preliminary report suggested that adding all-trans retinoic acid (ATRA) to ESAs may improve their
Autor:
Thomas Winkler, Arnold Ganser, Christoph W. M. Reuter, Anika Großhennig, A.S. Merseburger, Viktor Grünwald, Philipp Ivanyi
Publikováno v:
World Journal of Urology. 28:311-317
Multi-targeted tyrosine kinase inhibitors (MTKIs) are the standard in the treatment of metastatic renal cell carcinoma (mRCC). In spite their clinical activity, interaction with physiological functions has been shown. Here, we report on alterations o
Autor:
Kensei Tobinai, Takashi Watanabe, Sung-Won Kim, Akiko Miyagi Maeshima, Hirokazu Taniguchi, Dai Maruyama, Junko Nomoto, Yoshihiro Matsuno, Yukio Kobayashi
Publikováno v:
Cancer science. 100(1)
Rituximab is a chimeric monoclonal antibody that recognizes the CD20 antigen. It has been used to treat B-cell non-Hodgkin lymphoma (B-NHL), but recently rituximab resistance has been a cause for concern. We examined histological and immunohistochemi
Publikováno v:
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 37(18)
OBJECTIVE: In order to find out the condition of patients who used the Shuxuetong injection and provide reference and guidance for clinical practice, we analyzed the data of related indicators in patients in the HIS based of the frequency analysis me
Autor:
Yin Ching Chuang, Wen Chien Ko
Publikováno v:
Clinical Infectious Diseases. 20:1298-1304
Fifty-nine episodes of bacteremia due to Aeromonas species occurred within a 5-year period in one medical center in southern Taiwan. Underlying diseases in the 58 patients included hepatic cirrhosis (36%) and cancer (24%). Patients with aeromonas bac
Publikováno v:
The Prostate. 15:327-333
Fifty-nine hormonally treated prostatic carcinoma patients were prospectively followed by rectal palpation and fine needle aspiration cytology (FNAC) at 6 month intervals for periods ranging from 6 to 120 months (median follow-up, 48 months). The cyt
Autor:
Fritz Offner, Karima Amaador, Kazem Nasserinejad, Dries Deeren, Efstathios Kastritis, Steven T. Pals, Willem Kraan, Jeanette K. Doorduijn, Roberto D Liu, Monique C. Minnema, Marcel Kap, Marie José Kersten, Lara H Böhmer, Lidwine W. Tick, Meletios A. Dimopoulos, Josephine M.I. Vos, Martine E D Chamuleau, Maria Gavriatopoulou
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(1), 40-51. American Society of Clinical Oncology
Kersten, M J, Amaador, K, Minnema, M C, Vos, J M I, Nasserinejad, K, Kap, M, Kastritis, E, Gavriatopoulou, M, Kraan, W, Chamuleau, M E D, Deeren, D, Tick, L W, Doorduijn, J K, Offner, F, Böhmer, L H, Liu, R D, Pals, S T & Dimopoulos, M A 2022, ' Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia : Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 40, no. 1, pp. 40-51 . https://doi.org/10.1200/JCO.21.00105
Journal of clinical oncology, 40(1), 40-51. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(1), 40-51. American Society of Clinical Oncology
Kersten, M J, Amaador, K, Minnema, M C, Vos, J M I, Nasserinejad, K, Kap, M, Kastritis, E, Gavriatopoulou, M, Kraan, W, Chamuleau, M E D, Deeren, D, Tick, L W, Doorduijn, J K, Offner, F, Böhmer, L H, Liu, R D, Pals, S T & Dimopoulos, M A 2022, ' Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia : Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 40, no. 1, pp. 40-51 . https://doi.org/10.1200/JCO.21.00105
Journal of clinical oncology, 40(1), 40-51. American Society of Clinical Oncology
PURPOSE Proteasome inhibitors are effective in Waldenström's macroglobulinemia (WM) but require parenteral administration and are associated with polyneuropathy. We investigated efficacy and toxicity of the less neurotoxic oral proteasome inhibitor